JP2008516914A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516914A5
JP2008516914A5 JP2007536105A JP2007536105A JP2008516914A5 JP 2008516914 A5 JP2008516914 A5 JP 2008516914A5 JP 2007536105 A JP2007536105 A JP 2007536105A JP 2007536105 A JP2007536105 A JP 2007536105A JP 2008516914 A5 JP2008516914 A5 JP 2008516914A5
Authority
JP
Japan
Prior art keywords
fluorinated
alkyl
compound according
alkoxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007536105A
Other languages
English (en)
Japanese (ja)
Other versions
JP5193602B2 (ja
JP2008516914A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/011091 external-priority patent/WO2006040178A1/en
Publication of JP2008516914A publication Critical patent/JP2008516914A/ja
Publication of JP2008516914A5 publication Critical patent/JP2008516914A5/ja
Application granted granted Critical
Publication of JP5193602B2 publication Critical patent/JP5193602B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007536105A 2004-10-14 2005-10-14 ドーパミンｄ３受容体の調節に応答する障害の治療に好適なアリールスルホニルメチルまたはアリールスルホンアミド置換芳香族化合物 Expired - Fee Related JP5193602B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61877604P 2004-10-14 2004-10-14
US60/618,776 2004-10-14
US71194205P 2005-08-26 2005-08-26
US60/711,942 2005-08-26
PCT/EP2005/011091 WO2006040178A1 (en) 2004-10-14 2005-10-14 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor

Publications (3)

Publication Number Publication Date
JP2008516914A JP2008516914A (ja) 2008-05-22
JP2008516914A5 true JP2008516914A5 (https=) 2008-11-27
JP5193602B2 JP5193602B2 (ja) 2013-05-08

Family

ID=35709095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536105A Expired - Fee Related JP5193602B2 (ja) 2004-10-14 2005-10-14 ドーパミンｄ３受容体の調節に応答する障害の治療に好適なアリールスルホニルメチルまたはアリールスルホンアミド置換芳香族化合物

Country Status (20)

Country Link
US (1) US8969552B2 (https=)
EP (2) EP1812416B1 (https=)
JP (1) JP5193602B2 (https=)
KR (2) KR101325519B1 (https=)
CN (2) CN103073460B (https=)
AU (1) AU2005293694B2 (https=)
BR (1) BRPI0516115A (https=)
CA (1) CA2583779C (https=)
CR (2) CR9057A (https=)
EC (1) ECSP077394A (https=)
ES (2) ES2529720T3 (https=)
IL (2) IL182429A (https=)
MA (1) MA28952B1 (https=)
MX (1) MX2007004356A (https=)
NO (1) NO20072418L (https=)
NZ (2) NZ555124A (https=)
RU (1) RU2442781C2 (https=)
TW (1) TWI361806B (https=)
WO (1) WO2006040178A1 (https=)
ZA (1) ZA200703060B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
CA2844275A1 (en) * 2011-08-05 2013-02-14 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CN103130685A (zh) * 2011-12-01 2013-06-05 上海药明康德新药开发有限公司 一种(2,2-二甲基-5-氧-环己基)-氨基甲酸苄酯的制备方法
CA2954088A1 (en) 2014-07-30 2016-02-04 F.Hoffmann-La Roche Ag 6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives as taar modulators
WO2018083171A1 (en) 2016-11-02 2018-05-11 AbbVie Deutschland GmbH & Co. KG Spiro-compounds as s1p modulators
AU2019414251B2 (en) 2018-12-26 2025-02-27 Toray Industries, Inc. Cyclic amine derivative as agent for promoting advillin function, and novel cyclic amine derivative and pharmaceutical use thereof
CN119874465B (zh) * 2025-01-15 2025-12-19 海南大学 一种合成氟烷基取代4,4'-二氨基二苯甲烷类化合物的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
AU679053B2 (en) * 1993-03-25 1997-06-19 Pharmacia & Upjohn Company Indoletetralins having dopaminergic activity
CN1154693A (zh) * 1994-08-05 1997-07-16 美国辉瑞有限公司 具有多巴胺能活性的苯并咪唑衍生物
HUP9802034A3 (en) * 1995-04-04 2000-04-28 Encysive Pharmaceuticals Inc H Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin and use of the compounds
SI0923542T1 (en) * 1996-05-31 2004-02-29 Pharmacia & Upjohn Company Aryl substituted cyclic amines as selective dopamine d3 ligands
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
DE19922443A1 (de) 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
EP1198231A1 (en) * 1999-07-21 2002-04-24 American Home Products Corporation Bicyclic antagonists selective for the(alpha)v(beta)3 integrin
SE0001899D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
WO2003013507A1 (en) * 2001-08-09 2003-02-20 The United States Of America As Represented By Department Of Veterans Affairs Method of preventing or reducing the occurrence of symptoms of psychosis
JP2005505586A (ja) 2001-10-04 2005-02-24 ワイス ５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체
SE0301884D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use III

Similar Documents

Publication Publication Date Title
AU2018282336B2 (en) Trk-inhibiting compound
JP7033079B2 (ja) 芳香族スルホンアミド誘導体
ES2691068T3 (es) Compuestos de indol e indazol como inhibidores de la necrosis celular
IL324078A (en) Fused ring compounds
KR101464060B1 (ko) 피라졸-4-일-헤테로사이클릴-카복사마이드 화합물 및 사용 방법
CA2710182A1 (en) Pyrimidyl indoline compound
JP2020515575A5 (https=)
JP2011509309A5 (https=)
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
JP2008513516A5 (https=)
JP2005506290A5 (https=)
WO2022166974A1 (zh) 吡啶并嘧啶酮类衍生物及其制备方法和用途
CN117865939A (zh) 氨基嘧啶类衍生物抑制剂、其制备方法和应用
JP2008516914A5 (https=)
CN111094254B (zh) 杂芳基类衍生物、其制备方法及其在医药上的应用
KR20120013266A (ko) 세포괴사 저해제로서의 인돌 및 인다졸 화합물
WO2024193641A1 (zh) 异吲哚啉衍生物和苯并吲哚衍生物及其应用
JP2012522806A (ja) 抗ウイルス処置のためのインドール誘導体および方法
RU2007117802A (ru) Арилсульфонилметильные или арилсульфонамидные производные ароматических соединений, фармацевтическая композиция на их основе и способ лечения расстройств, восприимчивых к лечению лигандами дофаминовых d3 рецепторов, с их помощью
PE20071086A1 (es) DERIVADOS DE PIRAZOLOISOQUINOLINA COMO INHIBIDORES DE LA CINASA p38
CN116897155A (zh) 用于治疗和预防乙型肝炎病毒感染的苯并噻唑基双环[1.1.1]戊烷衍生物
RU2198170C2 (ru) Производные пиррола, фармацевтические композиции на их основе и способ лечения